P-glycoprotein (encoded by multidrug resistance genes), a member of the ATP-binding cassette transporter protein superfamily, has been shown to play a role in the secretion of cytokines. This conclusion was based upon the inhibition of cytokine secretion by anti-P-gp monoclonal antibodies. In this study, we show that anti-CD3-stimulated lymphocytes from wild-type, mdr1a knock out and mdr1ab double knock out mice produce similar amounts of IL-2, IFN-␥, IL-4, and IL-10. In addition, Jurkat T cells that lack P-gp and MDR1-transfected Jurkat T cells (Jurkat P-gp ) as well as purified human peripheral blood CD4 + P-gp + and CD4 + P-gp − and CD8 + P-gp + and CD8 + P-gp − T cell subsets produced comparable amounts of IL-2. These data show that P-gp is not required for secretion of IL-2, IFN-␥, IL-4, and IL-10 secretion in mice and IL-2 secretion in humans. Genes and Immunity (2000) 1, 371-379.
Introduction
P-glycoproteins (140-170 kDa) were originally identified by their ability to confer multidrug resistance (MDR) in a variety of tumor cells by extruding a wide range of structurally unrelated amphiphilic hydrophobic drugs. 1 In mammals, a small family of closely related genes [2] [3] [4] [5] [6] [7] [8] encodes P-glycoprotein (P-gp) with two members of the family in humans (MDR1 and MDR3) and three members in rodents (mdr1a, mdr1b, and mdr2). MDR1, mdr1a, and mdr1b confer MDR, whereas the closely related MDR3 and mdr2 do not. Human P-gp is widely expressed in a variety of tissues. 9, 10 Their apical location on a variety of secretory cells have suggested that P-gp may have a physiological function in protecting the organism against toxic xenobiotics by active transport of these compounds into bile, urine or intestine.
11,12 P-gp is also expressed in the adrenal cortex and placenta and transports some natural steroids; therefore, a physiological role in steroid secretion has been suggested. 13, 14 P-gp has also been suggested to play a role in volume-regulated chloride channel activity. 15 In rodents, these suggested roles appear to be somewhat divided between the highly related mdr1a and mdr1b genes. Although mdr1a and mdr1b are largely overlapping, they differ to some extent in drug transport capacity and tissue distribution. 5, 16, 17 The cells of the immune system appear to have similar levels of both mdr1a and mdr1b.
In humans, P-gp is expressed in a wide variety of the hematopoietic cells, including CD34 + stem cells, T and B lymphocytes, thymocytes, monocytes, and natural killer cells. [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] Originally, we proposed that P-gp might play a physiological role in the transport of certain cytokines and growth factors. 25 Later Drach et al 34 and Raghu et al. 35 reported that anti-P-gp antibody inhibits cytokine secretion, including IL-2, and concluded that P-gp plays a physiological role in IL-2 and other cytokine secretion. However, a role of P-gp in the secretion of IL-2 and other cytokines appears unlikely because of the following reasons: (a) unusually high concentration (20 g/ml-100 g/ml) of anti-P-gp monoclonal antibodies are required to inhibit cytotoxic effector function or cytokine secretion; and (b) IL-2 contains signal sequence and thus may not require an additional mechanism for its secretion. Therefore, in the present study we investigated a direct role of P-gp in cytokine secretion, including IL-2 in humans and mice. Data from mdr1a and mdr1ab double knock out (KO) mice, MDR1 transfected Jurkat T cells, and P-gp + and P-gp − purified subpopulations of human peripheral blood CD4 + T cells and CD8 + T cells, show that P-gp is not required for cytokine production in humans and mice.
Results
Cytokine production by lymphocytes from mdr1a and mdr1ab knock out mice To confirm that KO mice were indeed lacking corresponding mdr1 genes, RT-PCR was performed, using specific primers. mdr1a KO and mdr1ab KO mice were negative for corresponding mRNAs (Figure 1a ). To determine any difference in IL-2 secretion, splenocytes from three animals from each wild type, mdr1a KO and mdr1ab KO Figure 1 (a) Expression of mdr1a KO and mdr1ab in KO mice. In order to determine that the mice used in the experiments were indeed KO for mdr1a and mdr1ab, total RNA was extracted and mdr1a and mdr1ab expression was analyzed by PCR, using specific primers. Wild type (lane 1) expressed both mdr1a and mdr1b, whereas mdr1a (lane 2) expressed only mdr1b, whereas mdr1ab KO (Lane 3) lacked both mdr1a and mdr1b. Drug-sensitive mouse leukemia P388 cell line that lacks mdr1 (lane 4) and multidrug resistant P388/ADR (Lane 5) cell line (that overexpresses mdr1) are used as negative and positive controls respectively. Lane 6 is a 100 bp DNA ladder marker. ␤-actin is used as an internal control. (b) IL-2 mRNA in lymphocytes from mdr1a KO and mdr1ab KO mice. Total RNA was extracted from anti-CD3-activated splenocytes from wild-type (lane 1), mdr1a KO (Lane 2) and mdr1ab double KO (Lane 3) mice and IL-2 mRNA was assessed by RT-PCR, using mouse IL-2 specific primers (MoIL-2). Mouse ␤-actin (Mo ␤-actin) was used as internal control. All three, wild type (lane 1), mdr1a KO (lane 2) and mdr1ab KO (lane 3) mice had similar levels of IL-2 mRNA. mice were stimulated separately with anti-CD3 monoclonal antibody for 24 and 48 h, supernatants collected and analyzed for IL-2, IFN-␥, IL-4, and IL-10 by ELISA and cells were used for extraction of RNA and examined for IL-2 mRNA. No significant difference was observed in IL-2 mRNA in anti-CD3-stimulated lymphocytes from wild-type and mdr1a KO and mdr1ab KO mice ( Figure  1b) . Furthermore, lymphocytes from both mdr1a and mdr1ab KO mice produced similar levels of IL-2, IFN-␥, IL-4, and IL-10 as produced by wild-type mice ( Figure  2a-d) .
These results demonstrate that P-gp is not essential for cytokine secretion by murine lymphocytes.
DNA synthesis and lymphocyte subsets in mdr1 KO mice Because IL-2 is required for T cell proliferation, we compared the proliferative response of lymphocyte from wild-type mice to that of mdr1a KO and mdr1ab KO mice. Mononuclear cells were incubated in the presence or absence of anti-CD3 monoclonal antibody or concanvalin A (Con A) for 72 h and 3 H incorporation was measured. Figure 3a shows that lymphocyte proliferative response to both anti-CD3 and Con A in mdr1 KO and mdr1ab KO mice was comparable to lymphocytes from wild-type mice.
We also examined whether mdr1 KO mice have a different lymphocyte phenotype. Mononuclear cells were incubated with FITC-or PE-conjugated monoclonal antibodies against CD3, CD4, CD8, and CD45R antigens, and isotype controls. Five thousand cells were acquired and analyzed by FACScan. Data in Figure 3b show that all subsets in mdr1a KO and mdr1ab KO mice were comparable to wild-type mice.
These data suggest that P-gp has no effect on development of lymphocyte subsets or lymphocyte proliferation in mice.
IL-2 secretion by P-gp
+ and P-gp − subsets of CD4 + and CD8 + T lymphocytes To further investigate a role of P-gp in IL-2 secretion and because IL-2 is predominantly produced by CD4 + T cells, CD4
+ and CD8 + T cells were purified from peripheral blood T lymphocytes (isolated from mononuclear cells from healthy volunteers by passing over nylon wool column) by magnetic separation using immunobeads and further separated in to P-gp + and P-gp − subsets using magnetic beads. Both P-gp + and P-gp − CD4 + T cells and CD8
+ T cells were incubated in the presence or absence of anti-CD3 for 24 hours at 37°C. At the end of incubation, culture supernatants were collected and analyzed for IL-2 by ELISA. Figure 4a shows no difference in IL-2 secretion between P-gp + and P-gp − subsets of CD4 + and CD8 + T cells (P Ͼ 0.5). To determine whether intracellular IL-2 might be preferentially synthesized in P-gp + T cells, MNC were activated with PMA and ionomycin. The cells were stained with PE-conjugated anti-P-gp monoclonal antibody or isotype control, permeabilized, and incubated with FITCconjugated anti-IL-2 monoclonal antibody or isotype control. Cells were gated for T cells, using anti-CD3 monoclonal antibody and 5000 cells were acquired and analyzed by dual color analysis using FACScan. Figure 4b shows that intracellular IL-2 was present in both P-gp + (10%) and P-gp − (19%) T cells.
IL-2 secretion by MDR1 transfected Jurkat T cells
Jurkat T cells are known to secrete IL-2 upon stimulation with anti-CD3 monoclonal antibody. However, they lack P-gp ( Figure 5 ). Therefore, Jurkat T cells were transfected with a MDR1 expression plasmid (pHA-MDR1) and expression of MDR1 mRNA was determined by RT-PCR, using specific primers. The expression of P-gp was measured with anti-P-gp monoclonal antibody and isotype controls, using FACScan. Data in Figure 6a show that control Jurkat T cells (lane 1) lacked MDR1 mRNA, whereas transfected Jurkat cells (Jurkat P-gp ) had good expression of MDR1 mRNA (lane 2). Figure 6b shows that almost all Jurkat P-gp T cells were positive for P-gp, whereas control Jurkat T cells lacked P-gp expression.
To determine a role of P-gp in IL-2 secretion by Jurkat T cells, both control Jurkat and Jurkat P-gp T cells were stimulated with anti-CD3 monoclonal antibody for 24 h, supernatants collected and analyzed for IL-2 secretion by ELISA. No increase in IL-2 secretion was observed in Jurkat P-gp cells compared to that secreted by P-gp − control Jurkat T cells ( Figure 7) . Furthermore, Figure 6a shows no significant difference in IL-2 mRNA between Jurkat T cells (lane 1) and Jurkat P-gp T cells (lane 2). We have also observed that Jurkat T cells that lack P-gp produce equal . Splenocytes were stimulated with anti-CD3; supernatants were collected at 24 h and 48 h intervals and analyzed for cytokines by ELISA assay. Experiments were performed in three animals separately) from each group. No significant difference was observed in any of the cytokine produced by mdr1a KO and mdr1ab KO as compared to wild-type mice.
or more IL-2 than produced by peripheral blood T cells (data not shown).
These data suggest that P-gp is not required for IL-2 secretion by Jurkat T cells or peripheral blood T cells.
Discussion
A role of P-glycoprotein, a member of the ABC transporter superfamily, in MDR in cancer cells is well-established. 36 However, its physiological role remains largely unknown. In the non-hematopoietic tissue, it is proposed that P-gp plays a physiological role ranging from acting as flipase to transport of peptides. 37, 38 However, any direct evidence to support these assigned functions to Pgp is lacking. The recently developed mice homozygous for a disruption of mdr1a and mdr1ab gene 38, 39 have provided a useful model to study some of the physiological functions of P-glycoprotein. These mice are viable and appear phenotypically normal; however, they show an increased sensitivity to the centrally neurotoxic pesticide and chemotherapeutic agents and demonstrate that P-gp is a major P-glycoprotein in the blood-brain barrier. 40 In the immune system, we proposed that P-gp might
Genes and Immunity play a role in the transport of cytokines and growth factors. 26 Young and Krasney 41 examined a role of P-gp in the secretion of IL-1␤ (that lacks signal sequence; therefore, its mechanism of secretion is unknown). The COS cells were transfected with vector encoding for precursor or mature IL-1␤ with or without transfection with a vector encoding for human MDR1 or MDR3. Cotransfection of COS cells with mature IL-␤ and MDR1 resulted in the secretion of IL-1-␤, demonstrating a role of P-gp in IL-1␤ secretion.
Drach et al 34 and Raghu et al 35 demonstrated that anti-P-gp monoclonal antibodies inhibit IL-2, IL-4, and IFN-␥ secretion from activated peripheral blood lymphocytes and concluded that P-gp transports these cytokines. However, we hypothesized that P-gp may not be required for cytokine secretion for the following reasons: (a) IL-2, IL-4, IL-10, and IFN-␥ have signal sequence and may not require additional mechanism for their secretion; (b) the concentrations of anti-P-gp monoclonal antibodies required to inhibit cytokine secretion are much higher than those required for efflux of dye or chemotherapeutic agents; (c) some anti-P-gp monoclonal antibodies have been shown to react with molecules other than P-gp (eg, Splenocytes from wild-type, mdr1a KO and mdr1ab KO mice were incubated with monoclonal antibodies and isotype control and analyzed for cell surface antigen with specific monoclonal antibodies and isotype controls by dual color flow cytometry. For DNA synthesis lymphocytes were activated with anti-CD3 or concanavalin A (Con A) for 3 days followed by pulsing with H thymidine for additional 18 h. DNA synthesis was measured by scintillation counter. All experiments were performed in three animals in each group.
C-219 reacts with myosin 12 ; and (d) Jurkat T cells, which lack P-gp, produce more IL-2 than P-gp + peripheral blood lymphocytes (unpublished observations). Therefore, we examined a role of P-gp in cytokine secretion using several direct approaches. In humans, we used control Jurkat T cells (that lack P-gp) and Jurkat T cells transfected with MDR-1 plasmid (Jurkat P-gp ), purified P-gp + and P-gp − peripheral blood T lymphocytes, and intracellular IL-2 in P-gp + and P-gp − lymphocytes. In rodents, we utilized lymphocytes from mdr-1a KO and mdr1ab KO mice; the mdr1ab is equivalent to human MDR1.
In mdr1 KO mice, we observed no significant difference in IL-2, IFN-␥, IL-4 or IL-10 secretion by anti-CD3-stimulated splenocytes from either mdr1a or mdr1ab KO mice as compared to wild-type mice. Furthermore, IL-2 mRNA in anti-CD3-stimulated lymphocytes from both mdr1a and mdr1ab KO mice was comparable to that in wild-type mice. Because IL-2 is important In T cell proliferation, we also examined anti-CD3-induced proliferation in wildtype and mdr1a or mdr1ab KO mice. DNA synthesis in both mdr1a and mdr1ab KO mice was comparable to wildtype mice. In order to exclude any possibility that changes in T cell subsets in mdr1 KO mice accounted for failure to demonstrate changes in IL-2 secretion, we examined the phenotype of T cell subsets with dual color flow cytometry, using FACScan. CD3 + , CD4
+ , and CD8 + were comparable in both mdr1 KO and wild-type mice. These data strongly suggest that P-gp plays no significant role in the secretion of cytokine or the development of lymphocyte subsets in mice.
In humans, we examined the secretion of IL-2 by anti-CD3-stimulated purified P-gp + and P-gp − subsets of CD4 + and CD8 + T cells from peripheral blood lymphocytes of healthy volunteers. Both CD4 + P-gp + and CD4 + P-gp-T cells produced comparable amounts of IL-2. Similarly, no significant difference was observed in IL-2 secretion by CD8 + P-gp + and CD8 + P-gp − T cells. As expected CD8 + T cells secreted less IL-2 as compared to CD4 + T cells. If Pgp was required for IL-2 secretion, we would have expected more IL-2 secreted by CD8 + T cells; CD8 + T cells express more P-gp than CD4
+ T cells. [20] [21] [22] [23] [24] Furthermore, both P-gp + and P-gp − lymphocytes were positive for intracellular IL-2.
To study a role of P-gp in IL-2 secretion by Jurkat T cells, we compared IL-2 secretion from anti-CD3-stimulated control Jurkat T cells and Jurkat P-gp T cells. Control Jurkat T cells lack P-gp at both mRNA and protein level, whereas Jurkat P-gp T cells expressed both MDR1 gene and P-gp. No increase in IL-2 secretion was observed by Jurkat P-gp T cells as compared to control Jurkat T cells. Furthermore, no significant difference was observed in IL-2 mRNA between the two cell lines. These data suggest that P-gp is not essential for IL-2 secretion in Jurkat T cells.
Because of the observations of Raghu et al 35 and Drach et al, 34 we examined the effect of anti-P-gp monoclonal antibody on in vitro anti-CD3-induced IL-2 secretion by peripheral blood lymphocytes. Anti-P-gp monoclonal antibody UIC-2), in a concentration-dependent manner, inhibited IL-2 secretion by anti-CD3-stimulated peripheral blood lymphocytes (data not shown). Furthermore, we observed that UIC-2 monoclonal antibody induced apoptosis in anti-CD3-stimulated peripheral blood lymphocytes (manuscript in preparation). Therefore, anti-Pgp-induced inhibition of cytokine secretion observed by Raghu et al 35 and Drach et al 34 might be due to (a) binding of UIC 2 monoclonal antibody, in addition to P-gp, to some molecules other than P-gp; and/or (b) cell loss via monoclonal anti-P-gp antibody-induced apoptosis of activated T cells.
Our data strongly suggest that P-gp is not required for IL-2 secretion in humans and mice. Therefore, a role of P-gp in T cell physiology, if any, remains to be defined. + and P-gp − T cells. Human peripheral blood MNC were stimulated with PMA and ionomycin for 24 h and intracellular IL-2 containing P-gp + and P-gp − T cells were analyzed with specific monoclonal antibodies and isotype controls, using FACScan. Cells were gated for T cells, using anti-CD3 monoclonal antibody. IL-2 containing cells were both P-gp + and P-gp
Experimental procedures

Mice
Figure 5 P-gp expression in Jurkat T cells. Graded amounts of protein (5 g, 10 g, and 20 g/well) from Jurkat T cells and HL-60/Tax (that expressed P-gp was used as positive control) were subjected to Western blotting by incubating with anti-P-gp monoclonal antibody (JSB-1) followed by incubation with anti-mouse HRP antibody. Jurkat T cells lacked P-gp expression.
Cell Lines
Jurkat T cell line was purchased from American Tissue Culture Collection (ATCC, clone E6-1 no. TIB 152: Rockville, MD, USA) and maintained in culture medium (RPMI-1640 medium supplemented with 2 mm glutamine, 100 g/ml each of penicillin and streptomycin, and 10% fetal bovine serum, FBS). HL60, a human promonocytic leukemia cell line and HL-60/Tax a MDR subline of
Genes and Immunity HL60 were a gift from Dr Kapil Bhalla, Emory University, Atlanta, GA, USA. HL60 lacks whereas HL60/Tax expresses P-gp both at the mRNA and protein level 42 and P388, a mouse lymphocytic leukemia cell line and P388/ADR a MDR subline of P388 that expresses P-gp both at the mRNA and protein level 43 were a gift from Dr Lewis Slater, University of California, Irvine, USA.
Reagents
Phorbol myristate 13-acetate (PMA), ionomycin, mitomycin C, brefeldin A, leupeptin, phenyl methyl sulphonyl fluoride (PMSF), aprotinin, and mouse IgG2a were purchased from Sigma Chemical Company (St Louis, MO, USA). Fetal bovine serum was purchased from Hyclone (Logan, UT, USA). RPMI1640, penicillin, and streptomycin were obtained from Irvine Scientific (Irvine, CA, USA). Monoclonal antibodies (moAbs) used were antihuman CD3 (Ortho Diagnostics, Raritan, NJ, USA), antihuman IL-2-FITC, and their isotype controls (Becton Dickinson, San Jose, CA, USA), anti-mouse CD3⑀ (Pharmingen, San Diego, CA, USA), anti-mouse CD4-FITC, CD8-PE, CD3-FITC, CD45R-Ly-5 (B-220) PE and their isotype controls (Caltag, Burlingame, CA, USA). The anti-P-gp mAbs used were: MRK16 (Gift from Dr T Tsuruo, University of Tokyo, Japan) to purify Pgp + and P-gp − T cells and PE conjugated anti-P-gp (Becton Dickinson) for cell surface staining. JSB-1 anti-P-gp monoclonal antibody for Western blotting was purchased from Signet Laboratories (Dedham, MA, USA). Gene- SHUTTLE-20 was purchased from Quantum Biotechnologies, Quebec, Canada. RT-PCR kit was obtained from Perkin-Elmer (Forest City, CA, USA). Magnetic beads were purchased from Dynal, Lake Success, NY, USA.
Transfection of Jurkat T cells with MDR-1 expression plasmid P-glycoprotein was expressed in Jurkat T cells by transfecting with an MDR1 expression plasmid (pHa-MDR1) provided by Dr Michael Gottesman, National Cancer Institute, NIH, Bethesda, MD, USA. 4.8 × 10 6 cells in 0.8 ml medium were added to six-well culture plates. Two l of GeneSHUTTLE-20, a liposomal formulation of lipid (Quantum Biotechnologies, Quebec, Canada) was diluted in 100 l of RPMI-1640. One g of pHa-MDR1 DNA was diluted with 100 l of RPMI-1640. The diluted DNA solution was mixed with diluted GeneSHUTTLE-20 solution and kept at room temperature for 1 h to allow the formation of DNA/liposome complex. The DNA/liposome complex was added to the cell suspension in a six-well culture plate. After 20 h of incubation at 37°C containing 5% CO 2 , 4 ml of culture medium was added to each well and cells were further incubated for 48-72 h. Cells were harvested for RNA isolation (for RT-PCR), analysis for surface P-gp expression by flow cytometry, and stimulation with anti-CD3 for IL-2 secretion.
RT-PCR mRNA transcripts of MDR1 and IL-2 were analyzed by RT-PCR with specific primers. In brief, total cellular RNA was extracted by guanidinium isothiocyanate phenolchloroform extraction method, 44 using Trizol (GIBCO, BRL, Gaithersburg, MD, USA). cDNA was synthesized with 0.1 g of total RNA and 2. Sense, 5Ј-TAAGCAAGGTCCCTGGTTGC-3Ј, antisense, 5Ј-CTTACGGCTTCAAGAGCCAC-3Ј Mouse IL-2. Sense, 5Ј-TTCAAGCTCCACTTCAAG CTCTACAGCGGAAG-3Ј and antisense, 5Ј-GACA GAAGGCTATCCATCTCCTCAGAAAGTCC-3Ј Mouse ␤-actin: Sense, 5Ј-GTGGGCCGCTCTAGGCAC CAA-3Ј and antisense, 5Ј-CTCTTTGATGTCACGCAC GATTTC-3Ј Human IL-2: Sense, 5Ј-ATGTACAGGATGCAACTCCTG TCTT-3Ј, antisense, 5Ј-GTTAGTGTTGAGATGATGCTT TGAC-3Ј PCR products were separated by 1.2% agarose gel electrophoresis and DNA bands were visualized by ethidium bromide staining. For quantitative PCR, PCR products were sized-fractionated by 6% PAGE and radioactivity was visualized by autoradiography. Each band in the developed film was quantified by densitometry using a scanner (QuantScan, Molecular Dynamics, CA, USA), and normalized according to the amount of ␤-actin detected in the same RNA sample. One hundred bp DNA ladder was used as a standard DNA size marker.
Cell culture
Mononuclear cells (MNC) were prepared from mice as well as from peripheral blood from healthy young human volunteers. Animals were killed by cervical dislocation under phenobarbital anesthesia. Single cell suspensions of splenic cells were prepared by gentle passage through nylon mesh. Erythrocytes from spleens were lysed by incubation in 0.83% NH4Cl and 20 mm Tris (pH 7.4) for 2 min. The cells were washed with HBSS and resuspended in culture medium (RPMI-1640 supplemented with penicillin, streptomycin, L-glutamine, and 10% FBS). Peripheral blood MNC were isolated from normal healthy human volunteers by Ficoll-Hypaque density gradient centrifugation. P-gp + and P-gp − cells were purified from peripheral blood. Jurkat T cells (ATCC, Rockville, MD, USA) were maintained in RPMI-1640 containing 10% FBS.
Separation of human peripheral blood P-gp
+ and P-gp − T cell subsets Plastic adherent cells (monocytes/macrophages) were removed by incubating MNC in petri dishes previously coated with 20% FBS. T cell enriched non-adherent cells were further isolated by passing the adherent celldepleted MNC through nylon wool column. Purified T cells were Ͼ97% CD3 + . T cells were further separated into CD4 + and CD8 + T cells by incubating them with magnetic beads coated with anti-CD4 or anti-CD8 monoclonal antibodies (CD4, CD8 Isolation Kits; Dynal, Lake Success, NY, USA) at 4°C for 30 min. Cells were mixed with goat anti-mouse IgG-coated magnetic beads and separated them by magnetic separator. The cells were detached from the beads by adding DETACHABEAD solution (Dynal). The purity of these subsets was greater than 95%. CD4
+ and CD8 + T cells were further separated into P-gp + and P-gp 
Cytokine production
Mouse splenocytes (1 × 10 6 cells/ml) from wild-type and KO mice were stimulated with 5 g/ml of anti-mouse-CD3 at 37°C in 5% CO 2 -containing humidified atmosphere and cell culture supernatants were collected at 24-and 48-h intervals. IL-2, IFN-␥, IL-4 and IL-10 levels were measured by ELISA (Biosource, Camarillo, CA, USA).
Jurkat and Jurkat P-gp T cells were cultured in the presence or absence of anti-human anti-CD3 (25 ng/ml) for 24 h. Cell culture supernatants were collected and IL-2 levels measured by ELISA (R & D Systems, Minneapolis, MN, USA).
Purified CD4
+ P-gp + and CD8
+ P-gp − T cells (1 × 10 6 ) were incubated with immobilized anti-CD3 or isotype control monoclonal antibody (Ortho Diagnostics) at 37°C. Immobilized antibodies were used to circumvent the requirement for monocytes in T cell activation. Antibodies were immobilized by incubating each well of a 12-well tissue culture plate with 500 l phosphate buffered saline (PBS) containing 1 g/ml of anti-CD3 or isotype control for 1 h at 37°C. The wells were washed with PBS prior to plating of Pgp + and P-gp − T cells. Cell culture supernatants were collected at 24 h after activation and IL-2 levels quantified by ELISA.
For intracellular staining, human peripheral blood MNC were cultured with PMA (25 ng/ml) and ionomycin (10 g/ml) for 24 h at 37°C. Brefeldin-A (10 g/ml) was added 6 h prior to termination of cultures. Cultured cells were washed with PBS and stained with PE-conjugated anti-P-gp monoclonal antibody or isotype control. Cells were then fixed with lysing solution (Becton Dickinson) and permeabilized with permeabilizing solution according to manufacturers instructions. The permeabilized cells were incubated with FITC-conjugated anti-human IL-2 monoclonal antibody or isotype control for 30 min, washed three times with PBS containing 0.5% BSA and 0.01%NaN 3 , and analyzed by FACScan.
Lymphocyte subsets
Cell surface staining was conducted using staining buffer consisting of PBS supplemented with 0.5% BSA and sodium azide. Mouse spleen cells were stained with FITC-CD4, PE-CD8 or FITC-CD3, and PE-CD45R Ly5 monoclonal antibodies or isotype controls. Phenotypic analysis of splenocytes was performed by dual color flow cytometry, using Becton-Dickinson FACScan. A minimum of 5000 lymphocyte-gated events were acquired and analyzed with consort 30 software program (Becton Dickinson).
DNA synthesis
Splenocytes (2 × 10 5 /well) were cultured in triplicate in round bottom tissue culture plates in the presence or absence of anti-mouse CD3 antibodies (5 g/ml) or Con A (5 g/ml). Cells were incubated for 48 h at 37°C in 5% CO 2 in RPMI 1640 tissue culture medium supplemented with 10% FBS, 2 mm glutamine and 100 g/ml of penicillin and streptomycin. At 24 h prior to termination of culture, 1 Ci of 3 H thymidine (specific activity 6.9 Ci/mMol, New England Nuclear Corporation, Boston, MA, USA) was added to each well. Cultures were harvested and 3 H thymidine incorporation into DNA was determined by scintillation spectrometer.
